Strong Industry Presence CancerLinQ operates within the hospitals and healthcare industry, focusing on cancer care quality enhancement and biomedical research, making it a key partner for organizations looking to improve oncology outcomes.

Expanding Collaborations Recent partnerships with Atropos Health and collaborations with organizations like ASCO demonstrate CancerLinQ’s active engagement in integrating real-world evidence and advancing cancer care solutions, presenting opportunities for technology and data integration sales.

Innovative Technology Stack Utilizing cloud services like Amazon Web Services and modern web frameworks such as Preact and Scala, CancerLinQ is well-positioned to adopt or upgrade healthcare analytics solutions tailored for cancer treatment data management.

Growth and Revenue With an estimated revenue between 25 million and 50 million dollars and active product development, CancerLinQ offers potential for sales in health IT, interoperability, and clinical decision support tools to support its growth initiatives.

Non-Profit Focused As a non-profit subsidiary of ASCO with a mission to improve cancer care, CancerLinQ represents a partnership opportunity for companies offering sustainable, impactful solutions aligned with healthcare quality improvement and research facilitation.